Equity Profile
Pre-Earnings Brief
Koninklijke Philips is a health care company that focuses on medical equipment and technology. With a market cap of $26 billion, it plays a significant role in the health care sector, particularly as demand for health technology continues to grow.
Earnings Per Share (EPS)
EPS is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
Revenue figures provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
0Q
EPS Beat Rate
50%
Avg EPS Surprise
+11.00%
Avg Stock Reaction
+1.62%
In Q3-2025, Philips reported an EPS of $0.22, which was significantly below the expected $0.36, resulting in a 40% negative surprise. Following this, the stock saw a modest increase of nearly 3% the next day.
Management Promises & Guidance
Analysts expect Philips to report an EPS of $0.19 and revenue of $3.9 billion for Q4-2025. The market is closely watching how the company addresses its recent earnings misses.
Bull Case
If Philips can exceed EPS estimates and show strong revenue growth, it may signal a turnaround in its financial performance and boost investor confidence.
Bear Case
Conversely, another earnings miss could raise concerns about the company's operational challenges and lead to further declines in stock price.
Earnings Per Share (EPS)
$0.19EPS is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$3.9BRevenue figures provide insight into the company's sales performance and market demand for its products.
Expectations
The print will turn on these two things.
Q1
Will Philips achieve an EPS of $0.19 or better?
This EPS figure is crucial for restoring investor confidence after recent misses.
Q2
What is the revenue outlook for the upcoming quarters?
Understanding revenue trends will help gauge the company's growth prospects and market demand.
Edge
Why consensus could be wrong
The consensus may underestimate Philips' potential for recovery, as recent operational improvements could lead to better-than-expected results.
Supporting Evidence
Despite recent misses, Philips has a history of bouncing back with strong earnings surprises.
The options market is pricing a significant move, suggesting that traders expect volatility that could favor a positive outcome.
Key Risk
If Philips can demonstrate improved operational efficiency and meet or exceed revenue expectations, it could challenge the current bearish sentiment.
Edge
Pre-commit to what would confirm each case.
This quarter's performance is critical as Philips has struggled with earnings misses, and the market is looking for signs of recovery.
Bull Confirmed If
An EPS of $0.19 or higher would confirm a positive outlook and potentially restore investor confidence.
Bear Confirmed If
An EPS below $0.19 would reinforce concerns about operational challenges and could lead to further stock declines.
Pre-Earnings Positioning
Implied Move
±10.29%
Historical Avg
±10.1%
The options market is pricing in a significant move of over 10% in either direction, indicating heightened uncertainty around the earnings report.
Options are pricing ±10.3% while PHG has averaged ±10.1% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.6%
30d HV
29.8%
Edge
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing in-line setup in Health Care
n=30Fade rate: 11 of 27 (41%)
This setup has occurred 30 times across Health Care in the last 2 years. 11 of 27 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 6.7%, with a raw directional average of +3.7% (modestly positive historical bias).
Edge
Smart-money positioning from the most recent 13F filings.
Institutional
5.26%
of float
Insider
0.00%
of float
Holders
390
institutions
Top Holders· as of Dec 2025
Exor N.V.
182,543,970 sh · $5.0B
18.96%
Flat
Mondrian Investment Partners Ltd
7,893,228 sh · $216.8M
0.82%
-0.2%
Fiduciary Management, Inc.
6,543,122 sh · $179.7M
0.68%
-8.9%
Dimensional Fund Advisors LP
4,424,902 sh · $121.6M
0.46%
-0.3%
Morgan Stanley
2,841,880 sh · $78.1M
0.30%
11.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Philips beats expectations, history suggests the stock could rise by around 1.31% on the day, confirming a positive turnaround.
In-Line / Cautious
If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance.
Miss
A miss could lead to a decline of about 1.53%, reflecting ongoing concerns about the company's performance.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AXSOME THERAPEUTICS